|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
EP0733103B1
(en)
|
1993-11-09 |
2004-03-03 |
Targeted Genetics Corporation |
Generation of high titers of recombinant aav vectors
|
|
DE69433922T2
(de)
|
1993-11-09 |
2005-07-28 |
Medical College Of Ohio, Toledo |
Stabile zellinie, die in der lage ist, das replikationsgen des adenoassoziertenvirus zu exprimieren
|
|
US5658785A
(en)
|
1994-06-06 |
1997-08-19 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
|
US5856152A
(en)
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
|
WO1996017947A1
(en)
|
1994-12-06 |
1996-06-13 |
Targeted Genetics Corporation |
Packaging cell lines for generation of high titers of recombinant aav vectors
|
|
FR2737730B1
(fr)
|
1995-08-10 |
1997-09-05 |
Pasteur Merieux Serums Vacc |
Procede de purification de virus par chromatographie
|
|
JPH11511326A
(ja)
|
1995-08-30 |
1999-10-05 |
ジエンザイム コーポレイション |
アデノウィルスおよびaavの精製
|
|
JPH11514853A
(ja)
|
1995-09-08 |
1999-12-21 |
ジエンザイム コーポレイション |
遺伝子治療のための改良されたaavベクター
|
|
US5910434A
(en)
|
1995-12-15 |
1999-06-08 |
Systemix, Inc. |
Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
|
|
EP1696036B1
(en)
|
1996-09-06 |
2010-04-21 |
The Trustees of The University of Pennsylvania |
Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells
|
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
CA2995542A1
(en)
|
1997-09-05 |
1999-03-11 |
Genzyme Corporation |
Methods for generating high titer helper-free preparations of recombinant aav vectors
|
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
JP2004514407A
(ja)
|
2000-04-28 |
2004-05-20 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
異種キャプシド中にシュードタイピングされたaav5キャプシドおよびaav5ベクターを含む組換えaavベクター
|
|
USH2191H1
(en)
*
|
2000-10-24 |
2007-06-05 |
Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
|
WO2002053703A2
(en)
|
2001-01-05 |
2002-07-11 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
US7250496B2
(en)
*
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
EP2606152B2
(en)
*
|
2010-08-18 |
2025-03-12 |
Fred Hutchinson Cancer Center |
Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)
|
|
CA2826273C
(en)
*
|
2011-02-10 |
2021-11-02 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
CA2842798C
(en)
|
2011-07-25 |
2021-02-23 |
Nationwide Children's Hospital, Inc. |
Recombinant virus products and methods for inhibition of expression of dux4
|
|
DE102012007232B4
(de)
|
2012-04-07 |
2014-03-13 |
Susanne Weller |
Verfahren zur Herstellung von rotierenden elektrischen Maschinen
|
|
JP2015092462A
(ja)
|
2013-09-30 |
2015-05-14 |
Tdk株式会社 |
正極及びそれを用いたリチウムイオン二次電池
|
|
WO2015141521A1
(ja)
|
2014-03-21 |
2015-09-24 |
株式会社日立国際電気 |
基板処理装置、半導体装置の製造方法及び記録媒体
|
|
JP6197169B2
(ja)
|
2014-09-29 |
2017-09-20 |
東芝メモリ株式会社 |
半導体装置の製造方法
|
|
US10538763B2
(en)
|
2015-01-16 |
2020-01-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulation of DUX4
|
|
CN116814590A
(zh)
*
|
2015-10-22 |
2023-09-29 |
布罗德研究所有限公司 |
Vi-b型crispr酶和系统
|
|
WO2017073619A1
(ja)
|
2015-10-26 |
2017-05-04 |
国立大学法人東京大学 |
悪性リンパ腫又は白血病の罹患の有無の判別方法並びに白血病の治療及び/又は予防のための薬剤
|
|
TN2018000163A1
(en)
*
|
2015-11-12 |
2019-10-04 |
Res Inst Nationwide Childrens Hospital |
Methods of treating muscular dystrophy
|
|
JP6966463B2
(ja)
*
|
2016-02-26 |
2021-11-17 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
組換えウイルス産物及びdux4エクソンスキッピングを誘導するための方法
|
|
BR112018070249A2
(pt)
*
|
2016-04-02 |
2019-01-29 |
Research Institute At Nationwide Children's Hospital |
sistema promotor de u6 modificada para expressão específica de tecido
|
|
EP3515506B1
(en)
*
|
2016-09-23 |
2023-09-13 |
University of Massachusetts |
Silencing of dux4 by recombinant gene editing complexes
|
|
US11160823B2
(en)
*
|
2016-11-07 |
2021-11-02 |
University Of Massachusetts |
Therapeutic targets for facioscapulohumeral muscular dystrophy
|
|
CN110959039B
(zh)
|
2017-03-15 |
2025-03-14 |
博德研究所 |
新型cas13b直向同源物crispr酶和系统
|
|
AU2018251801B2
(en)
|
2017-04-12 |
2024-11-07 |
Massachusetts Institute Of Technology |
Novel type VI CRISPR orthologs and systems
|
|
EP3640329A1
(en)
*
|
2018-10-18 |
2020-04-22 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Gene editing based cancer treatment
|
|
CA3203585A1
(en)
*
|
2020-11-30 |
2022-06-02 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for treating facioscapulohumeral muscular dystrophy (fshd)
|
|
US20240093191A1
(en)
*
|
2021-02-03 |
2024-03-21 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for treating disease associated with dux4 overexpression
|